ProfileGDS4718 / 210172_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 77% 76% 83% 79% 71% 73% 74% 67% 66% 68% 70% 77% 73% 77% 70% 62% 67% 80% 77% 83% 75% 77% 66% 60% 66% 69% 75% 82% 78% 79% 61% 67% 79% 62% 83% 78% 70% 74% 79% 78% 72% 79% 68% 77% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.5035777
GSM549102patient 115, normal, homogenized [OPG study]7.4171976
GSM549104patient 119, normal, homogenized [OPG study]8.2263383
GSM549108patient 138, normal, homogenized [OPG study]7.6547479
GSM549119patient 077, normal, homogenized [OPG study]6.9026371
GSM549133patient 032, cancer, homogenized [OPG study]7.2474473
GSM549139patient 042, cancer, homogenized [OPG study]7.2843474
GSM549099patient 107, normal, homogenized [OPG study]6.6212867
GSM549109patient 139, normal, homogenized [OPG study]6.5324366
GSM549110patient 046, normal, homogenized [OPG study]6.7014368
GSM549114patient 063, normal, homogenized [OPG study]6.8518370
GSM549122patient 082, normal, homogenized [OPG study]7.4991377
GSM549134patient 033, cancer, homogenized [OPG study]7.1257873
GSM549136patient 036, cancer, homogenized [OPG study]7.6040377
GSM549140patient 044, cancer, homogenized [OPG study]6.9360870
GSM549111patient 047, normal, homogenized [OPG study]6.3032562
GSM549113patient 057, normal, homogenized [OPG study]6.6046567
GSM549132patient 031, cancer, homogenized [OPG study]7.9000780
GSM549137patient 038, cancer, homogenized [OPG study]7.5740677
GSM549142patient 047, cancer, homogenized [OPG study]7.8618583
GSM549100patient 110, normal, homogenized [OPG study]7.267875
GSM549107patient 135, normal, homogenized [OPG study]7.5691677
GSM549115patient 068, normal, homogenized [OPG study]6.5873766
GSM549116patient 072, normal, homogenized [OPG study]6.1249360
GSM549120patient 078, normal, homogenized [OPG study]6.5843266
GSM549131patient 030, cancer, homogenized [OPG study]6.7966369
GSM549118patient 074, normal, homogenized [OPG study]7.3004775
GSM549129patient 027, cancer, homogenized [OPG study]8.1137682
GSM549123patient 088, normal, homogenized [OPG study]7.5965178
GSM549124patient 006, cancer, homogenized [OPG study]7.6579679
GSM549126patient 015, cancer, homogenized [OPG study]6.188261
GSM549128patient 025, cancer, homogenized [OPG study]6.6643267
GSM549103patient 117, normal, homogenized [OPG study]7.6629679
GSM549117patient 073, normal, homogenized [OPG study]6.2023762
GSM549138patient 041, cancer, homogenized [OPG study]8.2120483
GSM549141patient 045, cancer, homogenized [OPG study]7.7302378
GSM549130patient 028, cancer, homogenized [OPG study]6.8496170
GSM549101patient 111, normal, homogenized [OPG study]7.2675974
GSM549105patient 128, normal, homogenized [OPG study]7.7346779
GSM549106patient 134, normal, homogenized [OPG study]7.7984778
GSM549112patient 048, normal, homogenized [OPG study]7.0676172
GSM549125patient 011, cancer, homogenized [OPG study]7.6827679
GSM549127patient 024, cancer, homogenized [OPG study]6.7530468
GSM549135patient 035, cancer, homogenized [OPG study]7.658977